Studies on the site of action of a circulating anticoagulant in disseminated lupus erythematosus: Evidence that this anticoagulant inhibits the reaction between activated Stuart factor (factor X) and proaccelerin (factor V)
- 31 December 1963
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 35 (6) , 813-819
- https://doi.org/10.1016/0002-9343(63)90243-2
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Studies on the Nature of the Circulating Anticoagulant Directed against Antihemophilic Factor: With Notes on an Assay for Antihemophilic FactorBlood, 1962
- The isolation and purification of a bovine-plasma protein which is a substrate for the coagulant fraction of Russell's-viper venomBiochemical Journal, 1962
- The fractionation of Russell's-viper (Vipera russellii) venom with special reference to the coagulant proteinBiochemical Journal, 1962
- The Coagulant Action of Russell's Viper Venom; The Use of Antivenom in Defining its Reaction with a Serum FactorBritish Journal of Haematology, 1961
- STUDIES ON THE ACTION OF HAGEMAN FACTOR: EVIDENCE THAT ACTIVATED HAGEMAN FACTOR IN TURN ACTIVATES PLASMA THROMBOPLASTIN ANTECEDENT*Journal of Clinical Investigation, 1961
- CIRCULATING ANTICOAGULANTSMedicine, 1961
- A Plasma Coagulation Defect in Systemic Lupus Erythematosus Arising from Hypoprothrombinemia Combined with Antiprothrombinase ActivityBlood, 1960
- An Unusual Circulating Anticoagulant in Systemic Lupus ErythematosusActa Haematologica, 1956
- The Reaction of Blood Coagulation Factors with Brain ExtractBritish Journal of Haematology, 1955
- SYSTEMIC LUPUS ERYTHEMATOSUSMedicine, 1954